Previous 10 | Next 10 |
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its PREvalence ™ ddPCR ® SARS-CoV-2 Wastewater Quantification Kit, a sensitive, accurate, and cost-effective ...
Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board PR Newswire SHANGHAI , June 17, 2021 /PRNewswire/ -- Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic ...
Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC PR Newswire CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China , June ...
Targovax announces completed enrollment in the phase 1/2 trial with ONCOS-102 in combination with durvalumab in patients with advanced colorectal cancer with peritoneal malignancies - The trial is now fully recruited with a total of 33 patients enrolled with 30 patients in the f...
iSpecimen Announces Pricing of Initial Public Offering PR Newswire LEXINGTON, Mass. , June 16, 2021 /PRNewswire/ -- iSpecimen Inc. ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the pricing of its initial public offe...
Fingerpaint Acquires Splice, Boosting the Company's West Coast Presence The California-based healthcare communications firm will be fully integrated into Fingerpaint. PR Newswire SARATOGA SPRINGS, N.Y. and EMERYVILLE, Calif. , June 16, 2021 /PRNewswire/ -...
Nature Journal Publishes Prospective, Randomized Study Validating Signatera® for Prediction of Immunotherapy Benefit Landmark study is first to definitively show that the Signatera MRD test can identify bladder cancer patients likely to benefit from immunotherapy after surg...
Swift Biosciences Meets NGS Demands by Offering 1536-Plex UDIs Swift Normalase™ Unique Dual Indexing (UDI) Primer Plates for High Throughput Next-Generation Sequencing PR Newswire ANN ARBOR, Mich. , June 16, 2021 /PRNewswire/ -- Swift Biosciences ...
Aruvant Partners with Aldevron to Provide Key Plasmid Raw Materials Used to Manufacture Pipeline Products PR Newswire NEW YORK , BASEL, Switzerland and Fargo, N.D. , June 16, 2021 /PRNewswire/ -- Aruvant Sciences, a private company focused on developing g...
PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa PR News...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compare...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital M...